Drug-related problems in cardiac children
Related Experiment Video
Updated: Apr 26, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Nirmeen Sabry1, Samar Farid, Dalia Dawoud
1Department of Clinical Pharmacy, Faculty of Pharmacy Cairo University, Cairo, Egyptes Nonprofit Organization, Milan, Italy - nirmeen.sabry@pharma.cu.edu.eg.
Insights
Drug-related problems (DRPs) are frequent in pediatric cardiac care, with drug-drug interactions and dosing issues being most common. Clinical pharmacists are vital for identifying and resolving these issues to improve patient outcomes.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Pediatric Cardiology
Background:
- Drug-related problems (DRPs) are defined as events interfering with desired health outcomes.
- Pediatric cardiac patients face unique challenges in drug therapy management.
- Understanding DRPs in this population is crucial for optimizing care.
Purpose of the Study:
- To determine the frequency and characteristics of DRPs in pediatric patients.
- To identify common types of DRPs in a tertiary cardiac care setting.
- To provide evidence for targeted interventions and pharmacist involvement.
Main Methods:
- Prospective observational cohort study over three months.
- Inclusion of pediatric patients (0-18 years) in a cardiac care center.
- Daily review of medical records, medication charts, and lab data by clinical pharmacists.
Main Results:
- A total of 313 DRPs were identified in 60 pediatric patients (average 5.22 per patient).
- Most frequent DRPs included drug-drug interactions (45.69%), unnecessary medication (31.95%), and under-dosing (21.09%).
- Physicians accepted 65% of pharmacist-suggested interventions.
Conclusions:
- DRPs are highly prevalent in pediatric cardiac care, primarily involving drug interactions and dosing.
- Targeted prescriber education on drug interactions and dosing is recommended.
- Increased clinical pharmacist presence on wards is essential for DRP identification and resolution.
Background:
A drug-related problem (DRP) may be defined as "an event or circumstance involving drug therapy that actually or potentially interferes with the desired health outcome". Our aim was to determine the frequency and characteristics of DRPs in pediatric patients admitted to a tertiary cardiac care center in the Egyptian capital, Cairo.
Methods:
A prospective observational cohort study involving review of case notes for children aged 0-18 years, admitted to the medical ward and intensive care unit (ICU), was conducted at a tertiary cardiac care center in Egypt. Data collection took place over a three-month period. Daily reviews of patients' records, medication charts and laboratory data were undertaken by the clinical pharmacists to identify DRPs.
Results:
A total of 60 patients were included in the study (mean age 4.8 years; 53.33% males). Over a three-month period, a total of 313 DRPs were recorded corresponding to an average of 5.22 problems per patient. The most commonly recorded problems related to drug-drug interaction (45.69%), prescribing unnecessary medication (31.95%), under-dosing (21.09%), inappropriate medication (0.96%) and adverse drug reaction (0.32%). Prophylactic antibiotics represented the only unnecessarily prescribed medications. Of the pharmacist suggested interventions, 65% were accepted by the responsible physician.
Conclusions:
DRPs occurred frequently during the study period. Drug-drug interactions, drug choice and drug dosing problems represented the majority of the identified DRPs, necessitating targeted prescriber education interventions in these areas. There is a clear need for clinical pharmacists' involvement on the ward level to identify and rectify these frequently occurring and very costly problems.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Toxicity: Risk factors
Pharmaceutical Poisoning: Potential Scenarios
Cardiac Catheterization I: Pre-Procedure Overview
Drug Dosing: Infants and Children

